1-1 of 1
Jörg T Bittenbring
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD-guided zanubrutinib, venetoclax and obinutuzumab in relapsed CLL: primary endpoint analysis from the CLL2-BZAG trial

Clinical Trials & Observations
Moritz Fürstenau, Sandra Robrecht, Christof Schneider, Eugen Tausch, Adam Giza, Matthias Ritgen, Jörg T Bittenbring, Holger Hebart, Björn Schöttker, Anna Lena Lena Illert, Ullrich Graeven, Andrea Stoltefuss, Bernhard Heinrich, Robert Eckert, Anna-Maria Fink, Janina Stumpf, Kirsten Fischer, Othman Al-Sawaf, Florian Simon, Fanni Kleinert, Jonathan Weiss, Karl-Anton Kreuzer, Anke Schilhabel, Monika Brüggemann, Petra Langerbeins, Stephan Stilgenbauer, Barbara Eichhorst, Michael J Hallek, Paula Cramer
Journal: Blood
Blood blood.2024026685.
https://doi.org/10.1182/blood.2024026685
Published: 2025
Includes: Supplemental data